Developing new cancer therapies for patients with high-risk tumors

Cancer research developed into candidate drugs

Our goal is to develop a new cancer therapy for patients with aggressive high-risk tumors

New Researches

Fiftheen years of cancer research has generated potential candidate drugs that target the so called “undruggable” MYC, the main driver in more than 50% of all cancers.

Our vision is to create a new cancer therapy"

Our vision is to develop a new cancer therapy for patients with high-risk tumors

News from MyCural

As a start-up company taking part in networking events, the UIC business incubator and pharma conferences, we are glad to present our news here.

Investors

Driving technology for leading brands

Contactinformation

MyCural Therapeutics AB
ULLS VÄG 29 C
756 51 Uppsala

Phone: +46-706 603 686
Email: info@mycural.com